MATER DEI (MATD3) Main Indicators
Basic Data - MATD3
Company | MATER DEI |
Corporate Name | HOSPITAL MATER DEI S/A |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Novo Mercado |
Activity | |
Share | MATD3 |
Quote Date | 04/01/2025 |
Share Type | ON |
Last Closing | R$ 3.80 |
Quotation Factor | 1 Share |
Financial Volume | R$ 528.79 thousand |
Last Statement | DFP - 12/31/2024 |
Sector | Saúde |
Subsector | Serv.Méd.Hospit..Análises e Diagnósticos |
Segment | Serv.Méd.Hospit..Análises e Diagnósticos |
Participation Indexes | IGC, IGNM, ITAG |
Updated 04/02/2025 |
Relative Prices - MATD3
Price/Earnings | -3.81 |
Price/SBV | 0.89 |
Price/Net Sales | 0.58 |
Price/CFO | 9.74 |
Price/FCF | -23.04 |
Price/Total Assets | 0.30 |
Price/EBIT | -3.84 |
Price/Working Capital | 1.28 |
Price/NCAV | -0.69 |
EV/EBIT | -6.22 |
EV/EBITDA | -9.22 |
EV/Net Sales | 0.94 |
EV/CFO | 15.78 |
EV/FCF | -37.34 |
EV/Total Assets | 0.48 |
Company Market Cap | R$ 1.29 B |
Enterprise Value | R$ 2.09 B |
Current Financial Statement Date | 12/31/2024 |
Current Share Price | R$ 3.80 |
Share Price Date | 04/01/2025 |
Dividend Yield | 1.97% |
Updated 04/02/2025 |
Income Statement - MATD3
Net Revenue | R$ 2.23 B |
Gross Result | R$ 670.60 M |
EBIT | - R$ 335.85 M |
Depreciation and Amortization | - R$ 109.04 M |
EBITDA | - R$ 226.81 M |
Net Profit | - R$ 338.44 M |
Net Profit/Share | - R$ 0.98 |
Updated 03/19/2025 |
Net Revenue | R$ 487.04 M |
Gross Result | R$ 129.03 M |
EBIT | R$ 50.65 M |
Depreciation and Amortization | - R$ 26.89 M |
EBITDA | R$ 77.54 M |
Net Profit | R$ 8.28 M |
Profit/Share | R$ 0.02 |
Updated 03/19/2025 |
Price and Volume Behavior - MATD3
Lowest Price 52 weeks | R$ 3.48 |
Highest Price 52 weeks | R$ 6.05 |
Variation 2025 | 9.20% |
Variation 1 year | -31.97% |
Variation 2 years(total) | -50.57% |
Variation 2 years(yearly) | -29.62% |
Variation 3 years(total) | -76.16% |
Variation 3 years(yearly) | -37.97% |
Variation 4 years(total) | - |
Variation 4 years(yearly) | - |
Variation 5 years(total) | - |
Variation 5 years(yearly) | - |
Average Daily Volume (3 months) | R$ 2.17 M |
Updated 04/02/2025 |
Returns and Margins - MATD3
Return on Initial Tangible Capital | -8.34% |
Return on Initial Invested Capital | -8.26% |
Pre-Tax Return on Initial Tangible Capital | -12.64% |
Pre-Tax Return on Initial Invested Capital | -12.52% |
Return on Initial Shareholder´s Equity | -20.45% |
Return on Initial Asset | -6.54% |
Gross Margin | 30.13% |
Net Margin | -15.20% |
EBIT Margin | -15.09% |
EBITDA Margin | -10.19% |
Initial Asset Turnover | 0.43 |
Financial Leverage | 3.00 |
Liabilities/Net Worth | 2.00 |
Net Debt/EBITDA | -3.53 |
Updated 03/19/2025 |
Balance Sheet - MATD3
Cash and Cash Equivalents | R$ 622.58 M |
Total Assets | R$ 4.34 B |
Short-Term Debt | R$ 75.90 M |
Long-Term Debt | R$ 1.35 B |
Gross Debt | R$ 1.42 B |
Net Debt | R$ 800.34 M |
Shareholder´s Equity | R$ 1.45 B |
Share Book Value | R$ 4.20 |
Common Shares | 345,157,525 |
Preferred Shares | 0 |
Total | 345,157,525 |
Common Shares in Treasury | 3,686,100 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 3,686,100 |
Common Shares (Except Treasury) | 341,471,425 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 341,471,425 |
Updated 03/19/2025 |
Cash Flow - MATD3
Operating Cash Flow | R$ 132.43 M |
Cash Flow from Investments | R$ 216.26 M |
Financing Cash Flow | R$ 46.59 M |
Increase (Reduction) in Cash and Equivalents | R$ 395.28 M |
Updated 03/19/2025 |
Operating Cash Flow | - R$ 16.52 M |
Cash Flow from Investments | - R$ 8.37 M |
Financing Cash Flow | - R$ 56.99 M |
Increase (Reduction) in Cash and Equivalents | - R$ 81.87 M |
Updated 03/19/2025 |
Experimental - MATD3
CAPEX 3 months | - R$ 21.19 M |
Free Cash Flow 3 months | - R$ 37.71 M |
CAPEX 12 months | - R$ 188.41 M |
Free Cash Flow 12 months | - R$ 55.98 M |
Updated 03/19/2025 |